Feng Y. Xu
22 Hankou Road
Nanjing, 210093, China
Nanjing, 210093, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 197 publications
Nanotechnology-Based Modulation of Autoimmune Microenvironments in Sjögren's Syndrome: A Review of Mechanistic Perspectives.
Journal: International journal of nanomedicine
Published: May 16, 2026
Corrigendum to "Pauci-Immune Endocapillary Proliferative Glomerulonephritis With Glomerular M2 Macrophage Infiltration" [Kidney International Reports Volume 11, Issue 4, April 2026, 103791].
Journal: Kidney international reports
Published: April 10, 2026
Pathogenesis of renal involvement in primary Sjögren's disease: convergence of multifactorial mechanisms on immune dysregulation.
Journal: Frontiers in immunology
Published: January 19, 2026
Reengineering 3D cellular-scale stiffness gradient at the enthesis with biomimetic hydrogels to promote in situ chondrogenesis.
Journal: Biomaterials
Published: January 17, 2026
A MXene nanoplatform for psoriasis therapy: Synergistic scavenging of ROS and cfDNA to target inflammation and proliferation.
Journal: Free radical biology & medicine
Published: December 01, 2025
Anti-PLA2R Antibody Trajectories for Predicting Prognosis in Patients with PLA2R-Associated Membranous Nephropathy.
Journal: American journal of nephrology
Published: November 13, 2025
Research trends and frontiers of the Apelin system in kidney diseases: a multi-database bibliometric analysis and cross-validation study.
Journal: International urology and nephrology
Published: November 10, 2025
Cell-type specific contribution of KLF4 to fibrotic nephropathy in tubular epithelium and fibroblast.
Journal: Cellular signalling
Published: November 05, 2025
Pauci-Immune Endocapillary Proliferative Glomerulonephritis With Glomerular M2 Macrophage Infiltration.
Journal: Kidney international reports
Published: October 13, 2025
A Decade-Long Journey of Steroid-Dependent IgA Nephropathy with Minimal Change Disease from Immunosuppressants to Rituximab and then to Obinutuzumab: A Case Report.
Journal: Case reports in nephrology and dialysis
Published: September 30, 2025
Biopsy-proven tyrosine kinase inhibitor-associated renal injury: a case series.
Journal: Clinical kidney journal
Published: September 23, 2025
Revealing Hidden Pathologies, Breaking Imaging Limits: Biomarker-Activated Nanoprobes Uncover Early Arthritis and Track Its Spatiotemporal Progression.
Journal: ACS biomaterials science & engineering
Published: August 18, 2025
Last Updated: 09/26/2026